News
News
- ROSEN, NATIONAL INVESTOR COUNSEL, Reminds Chembio Diagnostics, Inc. Investors of Important August 17 Deadline in Securities Class Action – CEMI
08/07/2020 / 23:45 - GlobeNewswire - Denali Therapeutics Reports Second Quarter 2020 Financial Results and Business Highlights
08/07/2020 / 22:30 - GlobeNewswire - Sprout Social to Present at Upcoming Investor Conferences
08/07/2020 / 22:30 - GlobeNewswire - Eidos Therapeutics Appoints Industry Leaders With Significant Development and Commercial Expertise to Board of Directors
08/07/2020 / 22:30 - GlobeNewswire - Akorn Provides Second Quarter 2020 Results
08/07/2020 / 22:24 - GlobeNewswire - Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling Across All Solid Cancers
08/07/2020 / 20:26 - GlobeNewswire - Amarin Supports Investigator-Initiated Trial at Kaiser Permanente in the U.S. to Study the Effects of VASCEPA® (icosapent ethyl) in Reducing Viral Upper Respiratory Infections, Including COVID-19 and Flu, and the Clinical Severity of Such Infections
08/07/2020 / 18:12 - GlobeNewswire - Merit Medical to Participate at Canaccord Genuity and Needham Conferences
08/06/2020 / 22:05 - GlobeNewswire - RedHill Biopharma Announces FDA Clearance for Pivotal Phase 3 Study with RHB-204 for NTM Infections
07/31/2020 / 13:00 - GlobeNewswire - Baudax Bio Announces Presentation of New Phase IIIb ANJESO® Data at the American Society of Colon and Rectal Surgeons 2020 Annual Scientific Meeting
07/30/2020 / 22:05 - GlobeNewswire
Real-time